Simvastatin

Simvastatin is a blood lipid-lowering drug suitable for the treatment of hyperlipidemia. It can effectively reduce blood cholesterol and low-density lipoprotein for primary hypercholesterolemia, slightly reduce triglyceride, and slightly increase high-density lipoprotein. In addition, Simvastatin can also improve the efficacy of vascular endothelial injury, or chronic inflammatory changes in the vascular endothelium.

For patients with homozygous familial hypercholesterolemia, Simvastatin combined with dietary control and non-dietary therapy can play a very good role. For patients with coronary heart disease and hypercholesterolemia, Simvastatin can reduce coronary heart disease mortality, the risk of non-fatal myocardial infarction, and the risk of stroke and transient cerebral ischemia. For surgical patients, Simvastatin can reduce the risk of cardiovascular reconstruction surgery, delay the degree of coronary arteriosclerosis, including reducing the formation of new lesions and blockages, has a good effect.

25kg/drum

USP/EP